Example: Heart Attack

Search clinical trials for: Anidulafungin

Total 39 results

NCT04045366

Recruiting

Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients

Conditions: Critically Ill Patients
NCT02021123

Completed

Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)

Conditions: Obesity Morbid
NCT01734525

Completed

Negative Beta Glucan in ICU Patients

Conditions: Candidemia
NCT01686607

Completed

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

Conditions: Systemic Fungal Infections
NCT01438216

Unknown status

Anidulafungin Pharmacokinetics in Intensive Care Unit Patients

Conditions: Invasive Candidiasis; Candidemia
NCT01307930

Completed

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Conditions: Obesity; Mycoses
NCT01303549

Completed

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients

Conditions: Liver Disease; Fungal Infection
NCT01270490

Unknown status

Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia

Conditions: Candidemia
NCT01249820

Completed

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Conditions: Leukemia; Myelodysplastic Syndrome; Leukemia, Myeloid, Acute
NCT01213823

Terminated

Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins

Conditions: Invasive Candidiasis; Candidemia
NCT01202253

Completed

Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom

Conditions: Candidiasis
NCT01188759

Withdrawn

Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

Conditions: Aspergillosis; Invasive Pulmonary Aspergillosis; Neuroaspergillosis
NCT01176058

Terminated

A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis

Conditions: Candidemia
NCT01053884

Terminated

Anidulafungin in Patients With Hematologic Malignancies

Conditions: Hematologic Malignancies
NCT01047267

Completed

Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)

Conditions: Invasive Candidiasis; Critically Ill
NCT00940017

Completed

A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Conditions: Aspergillosis; Candidemia
NCT00934934

Terminated

Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment

Conditions: Ventilator Associated Pneumonia; Respiratory Tract Infection
NCT00892359

Unknown status

Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)

Conditions: Acute Renal Failure; Infection
NCT00841971

Completed

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

Conditions: Mycoses; Fungemia; Central Nervous System Fungal Infections; Lung Diseases, Fungal
NCT00805740

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

Conditions: Candidiasis; Fungemia
NCT00806351

Terminated

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System

Conditions: Fungemia; Neutropenia; Candidiasis
NCT00802854

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

Conditions: Candidemia; Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)
NCT00761267

Completed

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Conditions: Candidemia
NCT00734500

Completed

Anidulafungin PK in Infants and Toddlers

Conditions: Invasive Fungal Infections
NCT00689338

Completed

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

Conditions: Invasive Candidiasis
NCT00672841

Completed

β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients

Conditions: Invasive Candidiasis
NCT00620074

Terminated

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Conditions: Aspergillosis
NCT00548262

Completed

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Conditions: Candidemia; Invasive Candidiasis
NCT00537329

Completed

Anidulafungin In Treatment Of Candidemia In Asian Subjects

Conditions: Candidemia
NCT00531479

Completed

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

Conditions: Aspergillosis
NCT00496197

Completed

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Conditions: Candidiasis
NCT00491426

Completed

Antimicrobial PK in Infants With Suspected or Confirmed Infection

Conditions: Infection
NCT00068471

Completed

Anidulafungin in Treating Immunocompromised Children With Neutropenia

Conditions: Infection; Neutropenia; Unspecified Childhood Solid Tumor, Protocol Specific
NCT00058682

Completed

Anidulafungin Versus Fluconazole in the Treatment of Candidemia

Conditions: Candida; Candidiasis
NCT00056368

Completed

The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis

Conditions: Candidiasis
NCT00056381

Completed

Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17

Conditions: Neutropenia
NCT00041704

Completed

The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)

Conditions: Candidiasis
NCT00037206

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Conditions: Aspergillosis
NCT00037219

Completed

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

Conditions: Candidiasis